Head-To-Head Analysis: BrainsWay (NASDAQ:BWAY) and Steakholder Foods (OTCMKTS:MTTCF)

BrainsWay (NASDAQ:BWAY) and Steakholder Foods (OTCMKTS:MTTCF) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Analyst Ratings

This is a summary of current recommendations for BrainsWay and Steakholder Foods, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrainsWay	0	1	2	0	2.67
Steakholder Foods	0	0	0	0	N/A

BrainsWay currently has a consensus target price of $7.00, suggesting a potential upside of 21.53%. Given BrainsWay’s higher possible upside, research analysts plainly believe BrainsWay is more favorable than Steakholder Foods.

Profitability

This table compares BrainsWay and Steakholder Foods’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BrainsWay	-13.20%	-10.05%	-6.88%
Steakholder Foods	N/A	N/A	N/A

Valuation & Earnings

This table compares BrainsWay and Steakholder Foods’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrainsWay	$31.78 million	3.02	-$4.20 million	($0.13)	-44.31
Steakholder Foods	N/A	N/A	N/A	N/A	N/A

Steakholder Foods has lower revenue, but higher earnings than BrainsWay.

Institutional & Insider Ownership

30.1% of BrainsWay shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

BrainsWay beats Steakholder Foods on 5 of the 8 factors compared between the two stocks.

About BrainsWay

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

About Steakholder Foods

Steakholder Foods Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter in Israel. The company develops a three-dimensional bioprinter to deposit layers of stem cells and differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provides associated products, such as cell lines, printheads, bioreactors, and incubators; and offers technology implementation, training, and engineering support services directly and through contractors to food processing, food retail, and cultivated meat companies. Steakholder Foods Ltd. is headquartered in Rehovot, Israel.